Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome

Area of Science:

• Epigenetics
• Cancer Biology
• Toxicology

Background:

• Non-genotoxic carcinogens induce liver cancer alongside epigenetic changes, particularly in DNA methylation.
• Investigating genome-wide 5-hydroxymethylcytosine (5hmC) dynamics as a potential intermediate in 5-methylcytosine (5mC) demethylation.
• Utilizing a rodent model with phenobarbital exposure to study these epigenetic perturbations.

Purpose of the Study:

• To explore the genome-wide dynamics of 5hmC in response to non-genotoxic carcinogen exposure.
• To understand the role of 5hmC as an intermediate in DNA methylation reprogramming pathways.
• To investigate the relationship between 5hmC, 5mC, and gene expression changes in the liver.

Main Methods:

• Rodent model exposed to the non-genotoxic carcinogen phenobarbital.
• Genome-wide analysis of DNA methylation (5mC) and hydroxymethylation (5hmC) patterns.
• Assessment of histone modifications (H3K4me2, H3K27me3, H3K36me3) and gene expression.

Main Results:

• Phenobarbital exposure caused dynamic, reciprocal changes in 5mC/5hmC patterns at promoters of upregulated genes.
• Reprogramming of 5mC/5hmC correlated with alterations in specific histone marks.
• Loss of both 5mC and 5hmC at transcription start sites, with increased 5hmC inversely related to 5mC loss near promoters.

Conclusions:

• 5hmC acts as a potential intermediate in DNA demethylation pathways.
• Phenobarbital exposure precisely perturbs the mouse liver DNA methylome and hydroxymethylome.
• Findings contribute to understanding epigenetic mechanisms in chemically induced liver cancer.